Israel - English - Ministry of Health

inovamed ltd - ondansetron as hydrochloride dihydrate - film coated tablets - ondansetron as hydrochloride dihydrate 8 mg - ondansetron - adults : ondansetron inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. for prevention and treatment of post operative nausea and vomiting (ponv).pediatric population : ondansetron inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 9.96 mg (equivalent: ondansetron, qty 8 mg) - injection, solution - excipient ingredients: water for injections; sodium citrate dihydrate; sodium chloride; citric acid monohydrate - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. prevention and treatment of post-operative nausea and vomiting.

New Zealand - English - Medsafe (Medicines Safety Authority)

aurobindo pharma nz limited - ondansetron hydrochloride dihydrate 9.972mg equivalent to 8 mg ondansetron - film coated tablet - 8 mg - active: ondansetron hydrochloride dihydrate 9.972mg equivalent to 8 mg ondansetron excipient: lactose magnesium stearate microcrystalline cellulose opadry yellow 03k52033 pregelatinised maize starch purified water - indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron tabs pfizer is also indicated for the prevention of post-operative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - ondansetron hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 9.98 mg (equivalent: ondansetron, qty 8 mg) - injection, solution - excipient ingredients: water for injections; citric acid monohydrate; sodium citrate dihydrate; hydrochloric acid; sodium chloride; sodium hydroxide - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.99 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium hydroxide; sodium chloride; water for injections; citric acid monohydrate; hydrochloric acid - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 9.98 mg (equivalent: ondansetron, qty 8 mg) - injection, solution - excipient ingredients: sodium citrate dihydrate; hydrochloric acid; water for injections; sodium chloride; citric acid monohydrate; sodium hydroxide - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.99 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; pregelatinised maize starch; sodium starch glycollate; colloidal anhydrous silica; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 10 mg (equivalent: ondansetron, qty 8 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; sodium starch glycollate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.